Dr. Philip M Arlen to present at DDIP 2025, March 3-4, 2015, San Diego, CA

Precision Biologics, Inc. CEO, Philip M Arlen, MD, will participate on an interactive panel (Day 1) and make the Featured Presentation (Day 2) at the WorldBI Drug Discovery Innovation Programme – DDIP 2025:
DDIP 2025 – Drug Discovery Innovation Programme, March 3-4, 2025, Hilton San Diego Bayfront, San Diego, CA

March 3 – Day 1
Session: Emerging Modalities in Drug Discovery
12:30pm Interactive Panel Discussion
From Start to Scale: Navigating Successful Exits in Drug Discovery Startups
Panelist – Philip M Arlen, CEO, Precision Biologics, Inc.

March 4 – Day 2
Session: Advancements in Biologics and Therapeutic Antibodies
5:10pm Featured Presentation
The Development of Monoclonal Antibodies Targeting Cancer
Speaker – Philip M Arlen, CEO, Precision Biologics, Inc.